Keyphrases
Adverse Events
10%
Anxiety-depression
5%
Area Index
6%
Asthma
6%
Atopic Dermatitis
100%
Bidirectional Association
5%
Cardiovascular Disease
5%
CCL17
6%
Childhood Dermatitis
5%
Children at Risk
5%
Comorbidity
5%
Confidence Interval
38%
Conjunctivitis
9%
Dupilumab
5%
Embase
10%
Food Allergy
5%
Food Challenge
5%
Food Sensitivity
5%
Hand Eczema
5%
Healthy Controls
5%
IL-17 Inhibitors
6%
IL-23 Inhibitors
10%
Immune Response
5%
Interleukin-17 (IL-17)
10%
Ixekizumab
6%
Medical Database
5%
Meta-analysis
70%
Moderate-to-severe Psoriasis
7%
Ocular Diseases
5%
Ocular Surface Disease
10%
PASI90
6%
Phase II Study
5%
Phase II Trial
5%
Pooled Odds Ratios
7%
Prospective Birth Cohort
6%
Psoriasis
18%
Psoriatic Arthritis
10%
PubMed
10%
Rhinitis
7%
Risk Factors
6%
RNA Sequencing (RNA-seq)
5%
Severity Index
6%
Skin Barrier Function
10%
Skin Biopsy
5%
Skin Microbiome
12%
Suicidal Ideation
5%
Systematic Meta-analysis
66%
Systemic Therapy
5%
Tape Stripping
8%
Web of Science
5%
Medicine and Dentistry
Acne Vulgaris
5%
Alcohol Consumption
5%
Atopic Dermatitis
35%
Contact Dermatitis
5%
Immune Response
5%
Insulin Dependent Diabetes Mellitus
5%
Interleukin 17
5%
Intervention Study
5%
Meta-Analysis
25%
Microbiome
10%
Ocular Surface Disease
5%
Odds Ratio
6%
Placebo
5%
Placebo Effect
5%
Population
5%
Prevalence
7%
Psoriasis
10%
Psoriasis Vulgaris
5%
Rhinitis
6%
Rhinophyma
5%
Systematic Review
25%
Systemic Therapy
5%
Thymus and Activation Regulated Chemokine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acne Vulgaris
5%
Adverse Event
10%
Atopic Dermatitis
45%
Cardiovascular Disease
5%
Comorbidity
6%
Dupilumab
5%
Ethanol
5%
Eye Disease
5%
Hand Eczema
5%
Interleukin 17
15%
Interleukin 23
10%
Intervention Study
5%
Microbiome
5%
Non Insulin Dependent Diabetes Mellitus
5%
Ocular Surface Disease
5%
Placebo
6%
Prevalence
14%
Psoriasis
18%
Psoriasis Vulgaris
6%
Psoriatic Arthritis
5%
Staphylococcus Aureus
6%
